News
IDIBELL renews ISO certifications in three key areas for the promotion of research at the Bellvitge Health Campus: innovation, biological sample management and promotion of independent clinical trials
Innovation, Biobank and UICEC: the three units have successfully passed their respective external audits, consolidating the excellence of research at IDIBELL
Science, art and education to transform learning: the IDIBELL-InsBellvitge Tandem closes the ninth year with new challenges overcome
The scientific illustration exhibition and the purchase of new microscopes for highschool’s laboratory have been the main activities of the academic year
“Thanks to REMMA Bellvitge, I have extended my life” (Andreu Clapés, patient with idiopathic pulmonary fibrosis)
When a disease takes your breath away, research can open new paths that allow you to keep breathing for longer
Increasing processed meat consumption by 30 grams raises gastric cancer risk by 9% and esophageal cancer risk by 13%
Evidence is expanding on the need to moderate the consumption of processed meat, such as cold cuts, ham, sausages or bacon, to reduce the risk of gastric and esophageal cancer.
A Heart-on-a-Chip to better understand how the human heart responds to drugs
An alternative to reduce the use of animal models and avoid the rejection of promising drugs due to an overestimation of their cardiac toxicity
Bellvitge turns a heart attack patient’s journey into an immersive experience to inspire future cardiovascular medicine professionals
360º programme, a pioneering initiative that integrates clinical care, translational research, simulation, innovation and artificial intelligence
Bellvitge’s female talent shines in the CSIC’s scientific impact ranking: 37 researchers among the most outstanding in Spain
The ranking recognizes the female researchers with the greatest scientific impact based on open-source bibliometric indicators
A study led by Bellvitge opens up a new option for the most difficult-to-treat migraine cases
About 30% of patients in whom preventive treatments had failed halved migraine days
Cancer also knows how to wait: an IDIBELL study uncovers the hidden step between a cancer-driving mutation and tumor biomass appearance
A mutation alone is not enough: tumour growth only begins when the environment provides the right conditions